Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices
The Drugs for Neglected Diseases initiative (DNDi) was created to develop new treatments for neglected diseases, and steers research towards specialised targeted product development, leveraging knowledge and knowhow of academia and industry, said Pascale Boulet, intellectual property & access …